Medical insurance reimbursement ratio for Venetoclax

Venetoclax/Venetoclax (Venetoclax) is a targeted therapy drug mainly used to treat specific types of hematological malignancies, especially chronic lymphocytic leukemia (CLL) and related hematological diseases. The drug works by targeting the activity of the BCL-2 (BCL-2) protein.

Venetoclax/Venetoclax has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Specifications100mg*14The price of 100mg*14 tablets is around 5000 yuan. Since the medical insurance reimbursement ratio is different in each region, for specific prices and medical insurance reimbursement ratio please consult the local hospital pharmacy or the medical insurance bureau .

There are original drugs and generic drugs abroad. The Turkish version of Venetoclax/Venetoclaxoriginal drug, specifications100mg*112tablets, is priced at more than 10,000 per box. Foreign generic drugs are relatively cheaper. For example, the generic drugs sold in Laos and Bangladesh are priced at about more than 4,000 yuan for 100mg*120 tablets. The ingredients of original drugs and generic drugs are basically the same.

BCL-2is an anti-apoptotic protein. OverexpressionBCL-2 will cause cancer cells to resist apoptosis, thereby promoting the unlimited proliferation of tumor cells. Venetoclax/Venetoclax is unique in its mechanism of action. It is an oral drug that can selectively inhibit the BCL-2 protein, allowing cancer cells to respond to apoptotic signals again, ultimately leading to the death of cancer cells.

Venetoc/VenetocIt has shown significant efficacy in clinical trials, especially in patients with refractory or relapsed CLL. Clinical study results show that Venetoclax/Venetoclax not only achieves significant improvements in patients' survival and quality of life, but also demonstrates deep control of leukemia cells, helping to slow the progression of the disease.

However, the use of venetoclax/venetoclax is also accompanied by a series of potential side effects, including pneumonia, tumor lysis syndrome, etc. Therefore, before using venetoclax/venetoclax, doctors will carefully evaluate the patient's condition and overall health to ensure that the patient can safely receive this treatment.